Growth delay in Down syndrome and zinc sulphate supplementation
β Scribed by Napolitano, G. ;Palka, G. ;Grimaldi, S. ;Giuliani, C. ;Laglia, G. ;Calabrese, G. ;Satta, M. A. ;Neri, G. ;Monaco, F.
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 321 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Growth retardation is a cardinal characteristic of Down syndrome (DS). It is most pronounced from the age of 6 months, when growth starts to become growth hormone (GH) regulated. DS children have normal serum levels of GH. GH regulates the production of insulin-like growth factors (IGFs), which act
## Background: Maternal folic acid supplementation has been associated with a reduced risk for neural tube defects and may be associated with a reduced risk for congenital heart defects and other birth defects. individuals with down syndrome are at high risk for congenital heart defects and have be